fluconazole has been researched along with Malignant Melanoma in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besser, MJ | 1 |
| Shapira-Frommer, R | 1 |
| Treves, AJ | 1 |
| Zippel, D | 1 |
| Itzhaki, O | 1 |
| Schallmach, E | 1 |
| Kubi, A | 1 |
| Shalmon, B | 1 |
| Hardan, I | 1 |
| Catane, R | 1 |
| Segal, E | 1 |
| Markel, G | 1 |
| Apter, S | 1 |
| Nun, AB | 1 |
| Kuchuk, I | 1 |
| Shimoni, A | 1 |
| Nagler, A | 1 |
| Schachter, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors[NCT01462903] | Phase 1 | 20 participants (Anticipated) | Interventional | 2011-09-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for fluconazole and Malignant Melanoma
| Article | Year |
|---|---|
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.
Topics: Acyclovir; Adult; Aged; Antifungal Agents; Antineoplastic Agents, Alkylating; Antiviral Agents; Cycl | 2009 |